Targeted Therapies Development in the Treatment of Advanced Nonsmall Cell Lung Cancer

por Gridelli, Cesare, Felip, Enriqueta
Publicado 2011

EURTAC first-line phase III randomized study in advanced non-small cell lung cancer: Erlotinib works also in European population

por Gridelli, Cesare, Rossi, Antonio
Publicado 2012

A potential new therapeutic option for patients with advanced EGFR mutation-positive non-small cell lung cancer in first-line setting

por Gridelli, Cesare, Losanno, Tania
Publicado en J Thorac Dis (2016)

The reproducibility of PD-L1 scoring in lung cancer: can the pathologists do better?

por Troncone, Giancarlo, Gridelli, Cesare
Publicado en Transl Lung Cancer Res (2017)

“Comparison of the toxicity profile of PD-1 versus PD-L1 inhibitors in non-small cell lung cancer”: is there a substantial difference or not?

por Spagnuolo, Alessia, Gridelli, Cesare
Publicado en J Thorac Dis (2018)

Immunotherapies in the management of epidermal growth factor receptor mutated non-small cell lung cancer: a role will be found?

por Casaluce, Francesca, Gridelli, Cesare
Publicado en Transl Lung Cancer Res (2018)

The combination strategies will be ready the right first-line choice for squamous lung cancer patients?

por Gridelli, Cesare, Casaluce, Francesca
Publicado en Transl Lung Cancer Res (2018)

Elderly patients and PD-L1-positive advanced non-small cell lung cancer: is pembrolizumab monotherapy effective and safe?

por Gridelli, Cesare, Sgambato, Assunta
Publicado en Ann Transl Med (2019)

The adjuvant regimen for resected EGFR mutated patients: the “same-for-all-therapy” or not?

por Gridelli, Cesare, Casaluce, Francesca
Publicado en Ann Transl Med (2020)

Narrative review of lung cancer treatment at the time of COVID-19 pandemia: pitfall and issues

por Casaluce, Francesca, Gridelli, Cesare
Publicado en Transl Lung Cancer Res (2021)

Management of lung cancer in older people

por Gridelli, Cesare., Audisio, Riccardo A.
Publicado 2013

The New Immunotherapy Combinations in the Treatment of Advanced Non-Small Cell Lung Cancer: Reality and Perspectives

por Rocco, Danilo, Gravara, Luigi D., Gridelli, Cesare
Publicado en Curr Clin Pharmacol (2020)

Lung cancer resection in octogenarian patients

por Spaggiari, Lorenzo, Petrella, Francesco, Maione, Paolo, Gridelli, Cesare
Publicado en J Thorac Dis (2018)

Targeting Immunometabolism Mediated by CD73 Pathway in EGFR-Mutated Non-small Cell Lung Cancer: A New Hope for Overcoming Immune Resistance

por Passarelli, Anna, Aieta, Michele, Sgambato, Alessandro, Gridelli, Cesare
Publicado en Front Immunol (2020)

Molecular and Genomic Profiling of Lung Cancer in the Era of Precision Medicine: A Position Paper from the Italian Association of Thoracic Oncology (AIOT)

por Normanno, Nicola, Barberis, Massimo, De Marinis, Filippo, Gridelli, Cesare
Publicado en Cancers (Basel) (2020)

Treatment of limited-stage small cell lung cancer in the elderly, chemotherapy vs. sequential chemoradiotherapy vs. concurrent chemoradiotherapy: that’s the question

por Gridelli, Cesare, Casaluce, Francesca, Sgambato, Assunta, Monaco, Fabio, Guida, Cesare
Publicado en Transl Lung Cancer Res (2016)

The role of pembrolizumab in the treatment of advanced non-small cell lung cancer

por Santabarbara, Giuseppe, Maione, Paolo, Rossi, Antonio, Palazzolo, Giovanni, Gridelli, Cesare
Publicado en Ann Transl Med (2016)

J-ALEX trial will crown alectinib as the standard choice for anaplastic lymphoma kinase positive untreated non-small cell lung cancer patients?

por Gridelli, Cesare, Casaluce, Francesca, Sgambato, Assunta, Palazzolo, Giovanni, Maione, Paolo
Publicado en J Thorac Dis (2018)

Lung cancer, elderly and immune checkpoint inhibitors

por Casaluce, Francesca, Sgambato, Assunta, Maione, Paolo, Spagnuolo, Alessia, Gridelli, Cesare
Publicado en J Thorac Dis (2018)

The optional approach of oncogene-addicted non-small cell lung cancer with brain metastases in the new generation targeted therapies era

por Spagnuolo, Alessia, Muto, Matteo, Monaco, Fabio, Colantuoni, Giuseppe, Gridelli, Cesare
Publicado en Transl Lung Cancer Res (2019)